tickertape
← runs

UNH

UNITEDHEALTH GROUP INCeval run
10-K for period ending 2025-12-31gpt-6-luna@none · prompt v4$0.00094.5sfiling on sec.gov ↗

figures

fieldvaluestatement rowprintedSEC
Total revenue$447.6BR7 Total revenues447,567 millions$447.6B ✓
Operating income$19.0BR14 Earnings from operations18,964 millions$19.0B ✓
Net income attributable to the company$12.1BR21 Net earnings attributable to UnitedHealth Group common shareholders12,056 millions$12.1B ✓
Diluted EPS$13.23R24 Diluted13.23$13.23 ✓
Cash and cash equivalents$24.4BR3 Cash and cash equivalents24,365 millions$24.4B ✓
Total assets$309.6BR14 Total assets309,581 millions$309.6B ✓
Total liabilities$207.9BR26 Total liabilities207,883 millions$207.9B ✓
Total shareholders' equity attributable to the company$100.1BR36 Total equity100,090 millions-
Net cash from operating activities$19.7BR17 Cash flows from operating activities19,697 millions$19.7B ✓
Net cash from investing activities-$8.7BR30 Cash flows used for investing activities(8,685) millions-$8.7B ✓
Net cash from financing activities-$11.6BR41 Cash flows used for financing activities(11,644) millions-$11.6B ✓

checks

  • assets = liabilities + equity · total assets equals total liabilities and equity
  • equity excludes minority interests · totalEquity excludes noncontrolling interests
  • net income is before preferred dividends · net income is not the after-preferred-dividends line
  • diluted EPS is for total net income · diluted EPS is for total net income
  • net income excludes minority interests · netIncome excludes noncontrolling interests
  • cash flows tie to the change in cash · operating + investing + financing (+ FX) equals the net change in cash

management's claims

Found 3 claims, none about a company-wide figure the statements can confirm.

trace

  1. 0locator (code)0.17s
    {
  "tables": 73,
  "exhibits": [],
  "documents": 1
}
    {
  "income": {
    "rows": 29,
    "scale": 1000000,
    "score": 51.25,
    "heading": "s to the Consolidated Financial Statements 41 Table of Contents UnitedHealth Group Consolidated Statements of Operations",
    "tableIndex": 20,
    "runnerUpScore": 30
  },
  "balance": {
    "rows": 38,
    "scale": 1000000,
    "score": 52.5,
    "heading": "We have served as the Company's auditor since 2002. 40 Table of Contents UnitedHealth Group Consolidated Balance Sheets",
    "tableIndex": 19,
    "runnerUpScore": 30.5
  },
  "cashflow": {
    "rows": 51,
    "scale": 1000000,
    "score": 55,
    "heading": "s to the Consolidated Financial Statements 44 Table of Contents UnitedHealth Group Consolidated Statements of Cash Flows",
    "tableIndex": 23,
    "runnerUpScore": 16.25
  }
}
  2. 1income statement agent1.66s · 1584 tokens · $0.0002
    {
  "rows": 29,
  "retryHint": null,
  "tableIndex": 20
}
    {
  "figures": [
    {
      "note": "Total revenues is the company-wide revenue line.",
      "field": "revenue",
      "scale": 1000000,
      "value": 447567000000,
      "printed": "447,567",
      "rowIndex": 7,
      "rowLabel": "Total revenues",
      "priorValue": 400278000000,
      "agentPrinted": "447,567",
      "failedChecks": [],
      "priorPrinted": "400,278",
      "groundingMismatch": false
    },
    {
      "note": "Earnings from operations is the statement’s operating income line.",
      "field": "operatingIncome",
      "scale": 1000000,
      "value": 18964000000,
      "printed": "18,964",
      "rowIndex": 14,
      "rowLabel": "Earnings from operations",
      "priorValue": 32287000000,
      "agentPrinted": "18,964",
      "failedChecks": [],
      "priorPrinted": "32,287",
      "groundingMismatch": false
    },
    {
      "note": "This is net earnings attributable to UnitedHealth Group common shareholders, excluding noncontrolling interests.",
      "field": "netIncome",
      "scale": 1000000,
      "value": 12056000000,
      "printed": "12,056",
      "rowIndex": 21,
      "rowLabel": "Net earnings attributable to UnitedHealth Group common shareholders",
      "priorValue": 14405000000,
      "agentPrinted": "12,056",
      "failedChecks": [],
      "priorPrinted": "14,405",
      "groundingMismatch": false
    },
    {
      "note": "This is diluted earnings per share attributable to UnitedHealth Group common shareholders.",
      "field": "epsDiluted",
      "scale": 1,
      "value": 13.23,
      "printed": "13.23",
      "rowIndex": 24,
      "rowLabel": "Diluted",
      "priorValue": 15.51,
      "agentPrinted": "13.23",
      "failedChecks": [],
      "priorPrinted": "15.51",
      "groundingMismatch": false
    }
  ],
  "statement": "income",
  "tableIndex": 20,
  "priorColumn": 1,
  "currentColumn": 0
}
  3. 2balance sheet agent1.67s · 1480 tokens · $0.0002
    {
  "rows": 38,
  "retryHint": null,
  "tableIndex": 19
}
    {
  "figures": [
    {
      "note": "This is the statement’s cash and cash equivalents line.",
      "field": "cash",
      "scale": 1000000,
      "value": 24365000000,
      "printed": "24,365",
      "rowIndex": 3,
      "rowLabel": "Cash and cash equivalents",
      "priorValue": 25312000000,
      "agentPrinted": "24,365",
      "failedChecks": [],
      "priorPrinted": "25,312",
      "groundingMismatch": false
    },
    {
      "note": "This row prints total assets.",
      "field": "totalAssets",
      "scale": 1000000,
      "value": 309581000000,
      "printed": "309,581",
      "rowIndex": 14,
      "rowLabel": "Total assets",
      "priorValue": 298278000000,
      "agentPrinted": "309,581",
      "failedChecks": [],
      "priorPrinted": "298,278",
      "groundingMismatch": false
    },
    {
      "note": "This is the standalone total liabilities line, not the combined liabilities-and-equity total.",
      "field": "totalLiabilities",
      "scale": 1000000,
      "value": 207883000000,
      "printed": "207,883",
      "rowIndex": 26,
      "rowLabel": "Total liabilities",
      "priorValue": 195687000000,
      "agentPrinted": "207,883",
      "failedChecks": [],
      "priorPrinted": "195,687",
      "groundingMismatch": false
    },
    {
      "note": "This is the only total equity line; no separate company-only total is printed.",
      "field": "totalEquity",
      "scale": 1000000,
      "value": 100090000000,
      "printed": "100,090",
      "rowIndex": 36,
      "rowLabel": "Total equity",
      "priorValue": 98268000000,
      "agentPrinted": "100,090",
      "failedChecks": [],
      "priorPrinted": "98,268",
      "groundingMismatch": false
    }
  ],
  "statement": "balance",
  "tableIndex": 19,
  "priorColumn": 1,
  "currentColumn": 0
}
  4. 3cash flow agent1.87s · 1784 tokens · $0.0002
    {
  "rows": 51,
  "retryHint": null,
  "tableIndex": 23
}
    {
  "figures": [
    {
      "note": "This row reports the operating activities section total after the changes in operating items.",
      "field": "operatingCashFlow",
      "scale": 1000000,
      "value": 19697000000,
      "printed": "19,697",
      "rowIndex": 17,
      "rowLabel": "Cash flows from operating activities",
      "priorValue": 24204000000,
      "agentPrinted": "19,697",
      "failedChecks": [],
      "priorPrinted": "24,204",
      "groundingMismatch": false
    },
    {
      "note": "This row reports the total cash used for investing activities.",
      "field": "investingCashFlow",
      "scale": 1000000,
      "value": -8685000000,
      "printed": "(8,685)",
      "rowIndex": 30,
      "rowLabel": "Cash flows used for investing activities",
      "priorValue": -20527000000,
      "agentPrinted": "(8,685)",
      "failedChecks": [],
      "priorPrinted": "(20,527)",
      "groundingMismatch": false
    },
    {
      "note": "This row reports the total cash used for financing activities.",
      "field": "financingCashFlow",
      "scale": 1000000,
      "value": -11644000000,
      "printed": "(11,644)",
      "rowIndex": 41,
      "rowLabel": "Cash flows used for financing activities",
      "priorValue": -3512000000,
      "agentPrinted": "(11,644)",
      "failedChecks": [],
      "priorPrinted": "(3,512)",
      "groundingMismatch": false
    }
  ],
  "statement": "cashflow",
  "tableIndex": 23,
  "priorColumn": 1,
  "currentColumn": 0
}
  5. 4reconciler (code)0.00s
    null
    [
  {
    "name": "balance_identity",
    "detail": "total assets equals total liabilities and equity",
    "fields": [
      "totalAssets"
    ],
    "passed": true,
    "skipped": false,
    "statement": "balance"
  },
  {
    "name": "totalEquity_attribution",
    "detail": "totalEquity excludes noncontrolling interests",
    "fields": [
      "totalEquity"
    ],
    "passed": true,
    "skipped": false,
    "statement": "balance"
  },
  {
    "name": "netIncome_before_preferred",
    "detail": "net income is not the after-preferred-dividends line",
    "fields": [
      "netIncome"
    ],
    "passed": true,
    "skipped": false,
    "statement": "income"
  },
  {
    "name": "epsDiluted_total",
    "detail": "diluted EPS is for total net income",
    "fields": [
      "epsDiluted"
    ],
    "passed": true,
    "skipped": false,
    "statement": "income"
  },
  {
    "name": "netIncome_attribution",
    "detail": "netIncome excludes noncontrolling interests",
    "fields": [
      "netIncome"
    ],
    "passed": true,
    "skipped": false,
    "statement": "income"
  },
  {
    "name": "cash_flow_tie",
    "detail": "operating + investing + financing (+ FX) equals the net change in cash",
    "fields": [
      "operatingCashFlow",
      "investingCashFlow",
      "financingCashFlow"
    ],
    "passed": true,
    "skipped": false,
    "statement": "cashflow"
  }
]
  6. 5MD&A claims agent1.89s · 1634 tokens · $0.0002
    null
    [
  {
    "kind": "percent_change",
    "field": "revenue",
    "quote": "Consolidated revenues grew 12%, UnitedHealthcare revenues grew 16% and Optum revenues grew 7%.",
    "scope": "segment_or_non_gaap",
    "actual": null,
    "reason": "Total revenue: about a segment, region or non-GAAP measure, which the statements can't confirm",
    "claimed": null,
    "verdict": "not_checked",
    "asWritten": "12%",
    "tolerance": null,
    "quoteVerified": true
  },
  {
    "kind": "percent_change",
    "field": "revenue",
    "quote": "Consolidated revenues grew 12%, UnitedHealthcare revenues grew 16% and Optum revenues grew 7%.",
    "scope": "segment_or_non_gaap",
    "actual": null,
    "reason": "Total revenue: about a segment, region or non-GAAP measure, which the statements can't confirm",
    "claimed": null,
    "verdict": "not_checked",
    "asWritten": "16%",
    "tolerance": null,
    "quoteVerified": true
  },
  {
    "kind": "percent_change",
    "field": "revenue",
    "quote": "Consolidated revenues grew 12%, UnitedHealthcare revenues grew 16% and Optum revenues grew 7%.",
    "scope": "segment_or_non_gaap",
    "actual": null,
    "reason": "Total revenue: about a segment, region or non-GAAP measure, which the statements can't confirm",
    "claimed": null,
    "verdict": "not_checked",
    "asWritten": "7%",
    "tolerance": null,
    "quoteVerified": true
  }
]

Income statement

table #20 · current period is figure column 1
0For the Years Ended December 31,
1(in millions, except per share data)202520242023
2Revenues:
3Premiums352,229308,810290,827
4Products53,38050,22642,583
5Services38,03836,04034,123
6Investment and other income3,9205,2024,089
7Total revenues← Total revenue447,567400,278371,622
8Operating costs:
9Medical costs313,995264,185241,894
10Operating costs59,59253,01354,628
11Cost of products sold50,65546,69438,770
12Depreciation and amortization4,3614,0993,972
13Total operating costs428,603367,991339,264
14Earnings from operations← Operating income18,96432,28732,358
15Interest expense(4,002)(3,906)(3,246)
16Loss on sale of subsidiary and subsidiaries held for sale(265)(8,310)-
17Earnings before income taxes14,69720,07129,112
18Provision for income taxes(1,890)(4,829)(5,968)
19Net earnings12,80715,24223,144
20Earnings attributable to noncontrolling interests(751)(837)(763)
21Net earnings attributable to UnitedHealth Group common shareholders← Net income attributable to the company12,05614,40522,381
22Earnings per share attributable to UnitedHealth Group common shareholders:
23Basic13.2815.6424.12
24Diluted← Diluted EPS13.2315.5123.86
25Basic weighted-average number of common shares outstanding908921928
26Dilutive effect of common share equivalents3810
27Diluted weighted-average number of common shares outstanding911929938
28Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents1266

Balance sheet

table #19 · current period is figure column 1
0(in millions, except per share data)December 31,2025December 31,2024
1Assets
2Current assets:
3Cash and cash equivalents← Cash and cash equivalents24,36525,312
4Short-term investments3,7563,801
5Accounts receivable, net of allowances of $1,208 and $98523,01822,365
6Other current receivables, net of allowances of $3,763 and $2,86429,69726,089
7Prepaid expenses and other current assets9,7468,212
8Total current assets90,58285,779
9Long-term investments54,25152,354
10Property, equipment and capitalized software, net of accumulated depreciation and amortization of $7,546 and $6,97110,76210,553
11Goodwill110,499106,734
12Other intangible assets, net of accumulated amortization of $7,472 and $8,35020,47423,268
13Other assets23,01319,590
14Total assets← Total assets309,581298,278
15Liabilities, redeemable noncontrolling interests and equity
16Current liabilities:
17Medical costs payable39,33734,224
18Accounts payable and accrued liabilities38,03234,337
19Short-term borrowings and current maturities of long-term debt6,0694,545
20Unearned revenues3,4133,317
21Other current liabilities28,04627,346
22Total current liabilities114,897103,769
23Long-term debt, less current maturities72,32072,359
24Deferred income taxes2,4213,620
25Other liabilities18,24515,939
26Total liabilities← Total liabilities207,883195,687
27Commitments and contingencies (Note 12)
28Redeemable noncontrolling interests1,6084,323
29Equity:
30Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding--
31Common stock, $0.01 par value - 3,000 shares authorized; 906 and 915 issued and outstanding99
32Additional paid-in capital559-
33Retained earnings95,60396,036
34Accumulated other comprehensive loss(2,061)(3,387)
35Nonredeemable noncontrolling interests5,9805,610
36Total equity← Total shareholders' equity attributable to the company100,09098,268
37Total liabilities, redeemable noncontrolling interests and equity309,581298,278

Cash flow statement

table #23 · current period is figure column 1
0For the Years Ended December 31,
1(in millions)202520242023
2Operating activities
3Net earnings12,80715,24223,144
4Noncash items:
5Depreciation and amortization4,3614,0993,972
6Deferred income taxes(1,752)(296)(245)
7Share-based compensation9711,0181,059
8Loss on sale of subsidiary and subsidiaries held for sale2658,310-
9Net gains on dispositions and other strategic transactions(910)(3,333)(489)
10Other, net1,673(28)(16)
11Net change in other operating items, net of effects from acquisitions and dispositions:
12Accounts receivable(764)(1,437)(3,114)
13Other assets(4,606)(4,140)(2,444)
14Medical costs payable5,8242,5033,482
15Accounts payable and other liabilities1,6652,4633,516
16Unearned revenues163(197)203
17Cash flows from operating activities← Net cash from operating activities19,69724,20429,068
18Investing activities
19Purchases of investments(17,373)(27,308)(18,314)
20Sales of investments9,28818,5147,307
21Maturities of investments8,4469,3199,230
22Cash paid for acquisitions and other transactions, net of cash assumed(4,509)(13,408)(10,136)
23Purchases of property, equipment and capitalized software(3,622)(3,499)(3,386)
24Loans to care providers - cyberattack-(9,033)-
25Repayments of care provider loans - cyberattack1,6804,514-
26Cash received from dispositions and other strategic transactions, net5612,041685
27Originations and purchases of loans(4,795)(2,477)(1,664)
28Repayments and maturities of loans1,980908613
29Other, net(341)(98)91
30Cash flows used for investing activities← Net cash from investing activities(8,685)(20,527)(15,574)
31Financing activities
32Common share repurchases(5,545)(9,000)(8,000)
33Cash dividends paid(7,916)(7,533)(6,761)
34Proceeds from common stock issuances8271,8461,353
35Repayments of long-term debt(3,050)(3,000)(2,125)
36Proceeds from (repayments of) short-term borrowings, net807(151)11
37Proceeds from issuance of long-term debt2,96917,8116,394
38Customer funds administered366(1,560)(521)
39Purchases of redeemable noncontrolling interests(165)(280)(730)
40Other, net63(1,645)(1,150)
41Cash flows used for financing activities← Net cash from financing activities(11,644)(3,512)(11,529)
42Effect of exchange rate changes on cash and cash equivalents40(61)97
43(Decrease) increase in cash and cash equivalents, including cash within businesses held for sale(592)1042,062
44Less: net increase in cash within businesses held for sale(355)(219)-
45Net (decrease) increase in cash and cash equivalents(947)(115)2,062
46Cash and cash equivalents, beginning of period25,31225,42723,365
47Cash and cash equivalents, end of period24,36525,31225,427
48Supplemental cash flow disclosures
49Cash paid for interest4,0303,5943,035
50Cash paid for income taxes3,7144,6206,078